Sickle Cell Disease (SCD) is a serious inherited blood disorder that continues to pose a significant public health challenge due to its lifelong health implications and potential complications. The condition affects haemoglobin, the protein responsible for carrying oxygen in the blood, causing red blood cells to become sickle-shaped. These abnormal cells can block blood flow, leading to anaemia, recurrent pain episodes, infections, and damage to vital organs. Despite advances in treatment, awareness and early diagnosis remain critical. Symptoms such as unexplained anaemia, jaundice, swelling of the hands and feet, frequent infections, fatigue, and growth delays should not be ignored. Timely screening, particularly during infancy and childhood, along with appropriate medical intervention, can significantly improve quality of life and reduce the risk of severe complications.
According to Dr. Tarun Verma, Senior Consultant & Regional Director, DM (Clinical Haematology), MD (Internal Medicine), Haemato-Medical Oncology, Cancer and Bone Marrow Transplant at Yatharth Super Speciality Hospital Noida Extension , “Sickle Cell Disease is a hereditary blood disorder belonging to a group of conditions called haemoglobinopathies. Haemoglobinopathies are disorders of haemoglobin production, either due to reduced production or the production of defective haemoglobin. In SCD, red blood cells become sickle-shaped, leading to anaemia, pain crises, and organ damage. It remains a major public health concern due to its lifelong impact and associated complications.”
Early symptoms can be anaemia without explanation, jaundice, swelling of the hands and feet, infections that keep coming back, feeling tired, stunted growth, and pain attacks. Early evaluation by a healthcare provider is critical for diagnosis and management.
Sickle Cell Disease can affect individuals of all age groups. However, early detection during infancy or childhood is crucial, as timely intervention can significantly improve long-term health outcomes. Less than 5% of patients visiting our OPD each month
SCD if left untreated, can cause severe anaemia, repeated pain crises, infections, stroke, organ damage, stunted growth, and poor quality of life. Early intervention contributes to lowering the chances of such problems.
Newborn screening and genetic counseling are very important. Early detection provides the opportunity for timely treatment, and genetic counseling assists families in understanding patterns of inheritance and in making informed decisions about reproduction.
Treatment includes medications such as hydroxyurea, vaccination, infection prevention, blood transfusions, and supportive care. Recent advancements include targeted therapies and stem cell transplantation, which offer improved outcomes for selected patients.
Patients need to keep themselves well-hydrated, avoid extreme temperature, treat infections early, have routine medical follow-ups and avoid overexertion which can bring on a sickle cell crisis.
